Salvatore Papa, Concetta Bubici  Journal of Hepatology 

Slides:



Advertisements
Similar presentations
EASL Clinical Practice Guidelines: Vascular diseases of the liver Journal of Hepatology Volume 64, Issue 1, Pages (January 2016) DOI: /j.jhep
Advertisements

Inflammasomes in liver diseases
Volume 50, Issue 4, Pages (April 2009)
Therapeutic vaccines and immune-based therapies for the treatment of chronic hepatitis B: Perspectives and challenges  Marie-Louise Michel, Qiang Deng,
Angiogenesis and hepatocellular carcinoma
Pathological roles of purinergic signaling in the liver
The inflammasome in liver disease
New directions for cell-based therapies in acute liver failure
Obesity, inflammation, and liver cancer
Matthew T. Kitson, Stuart K. Roberts  Journal of Hepatology 
Volume 47, Issue 1, Pages (July 2007)
Liver regeneration Journal of Hepatology
Volume 52, Issue 3, Pages (March 2010)
Volume 57, Issue 1, Pages 6-8 (July 2012)
Hedgehog signaling in the liver
The function of serotonin within the liver
Histamine regulation of biliary proliferation
IL-6 pathway in the liver: From physiopathology to therapy
Daniel A. Langer, Vijay H. Shah  Journal of Hepatology 
Regulatory T-cell directed therapies in liver diseases
Endoplasmic reticulum stress in liver disease
Nicolas Moniaux, Jamila Faivre  Journal of Hepatology 
Mesenchymal stromal cell therapy for liver diseases
Biology of the immunomodulatory molecule HLA-G in human liver diseases
Volume 66, Issue 2, Pages (February 2017)
The progenitor cell dilemma: Cellular and functional heterogeneity in assistance or escalation of liver injury  Veronika Lukacs-Kornek, Frank Lammert 
Targeting the gut-liver axis in liver disease
Inflammation and portal hypertension – The undiscovered country
From immunosuppression to tolerance
Regulatory T-cell directed therapies in liver diseases
Hepatitis C core protein – The “core” of immune deception?
Hypoxia inducible factors in liver disease and hepatocellular carcinoma: Current understanding and future directions  Garrick K. Wilson, Daniel A. Tennant,
Signalling pathways in alcohol-induced liver inflammation
Therapeutic vaccines and immune-based therapies for the treatment of chronic hepatitis B: Perspectives and challenges  Marie-Louise Michel, Qiang Deng,
Atsushi Miyajima, Minoru Tanaka, Tohru Itoh  Cell Stem Cell 
Hepatocyte-like cells differentiated from human induced pluripotent stem cells (iHLCs) are permissive to hepatitis C virus (HCV) infection: HCV study.
The quest for liver progenitor cells: A practical point of view
Targeting gut flora to prevent progression of hepatocellular carcinoma
Liver Sinusoidal Endothelial Cells: An Antiviral “Defendothelium”
Mechanisms of iron hepatotoxicity
Angiogenesis and hepatocellular carcinoma
Inhibition of mammalian target of rapamycin: Two goals with one shot?
Volume 45, Issue 4, Pages (October 2006)
Volume 59, Issue 3, Pages (September 2013)
Sinusoidal communication in liver fibrosis and regeneration
Mona Malz, Federico Pinna, Peter Schirmacher, Kai Breuhahn 
Bin Gao, Hua Wang, Fouad Lafdil, Dechun Feng  Journal of Hepatology 
Volume 66, Issue 1, Pages (January 2017)
Targeting STAT3 in hepatocellular carcinoma: Sorafenib again…
Cannabinoid signaling and liver therapeutics
Karel J. van Erpecum, Frank G. Schaap  Journal of Hepatology 
Liver fibrosis – from bench to bedside
Volume 50, Issue 4, Pages (April 2009)
Volume 59, Issue 2, Pages (August 2013)
Arjan Boltjes, Dowty Movita, André Boonstra, Andrea M. Woltman 
Volume 44, Issue 5, Pages (May 2006)
Role of desmoplasia in cholangiocarcinoma and hepatocellular carcinoma
Macrophage heterogeneity in liver injury and fibrosis
The dynamic biliary epithelia: Molecules, pathways, and disease
Silvia Affò, Ramón Bataller  Journal of Hepatology 
Volume 65, Issue 4, Pages (October 2016)
Statins: Old drugs as new therapy for liver diseases?
Pathogenesis of cholestatic hepatitis C
The balance between Notch/Wnt signaling regulates progenitor cells’ commitment during liver repair: Mystery solved?  Mario Strazzabosco, Luca Fabris 
Inflammatory pathways in alcoholic steatohepatitis
The origin of biliary strictures after liver transplantation: Is it the amount of epithelial injury or insufficient regeneration that counts?  Negin Karimian,
EpCAM in hepatocytes and their progenitors
Foxa1 and Foxa2 regulate bile duct development in mice
Volume 61, Issue 2, Pages (August 2014)
Niya Aleksieva, Stuart J. Forbes  Journal of Hepatology 
Presentation transcript:

Feeding the Hedgehog: A new meaning for JNK signalling in liver regeneration  Salvatore Papa, Concetta Bubici  Journal of Hepatology  Volume 69, Issue 3, Pages 572-574 (September 2018) DOI: 10.1016/j.jhep.2018.05.026 Copyright © 2018 European Association for the Study of the Liver Terms and Conditions

Fig. 1 The simplified representation of the crosstalk between the Hedgehog and JNK signalling pathways. Schematic drawing of the mechanisms of accelerated liver regeneration triggered by ALPPS hepatic resection. At the microscopic level, the liver consists of functional units called lobules, which are made mostly of hepatocytes (the most common type of liver cell), sinusoidal endothelial cells, biliary epithelial cells, Kupffer cells and hepatic stellate cells. Hepatic stellate cells and Kupffer cells closely interact with hepatocytes supporting cytokine and growth factor production needed for hepatocyte growth and survival. Following an injury or resection, the liver responds to reinstate the original mass by stimulating cellular proliferation. In the model described by Langiewicz and colleagues’ study,9 the authors propose a model whereby ALPPS-mediated liver regeneration is mediated by the accumulation of JNK in hepatic stellate cells. Nuclear active-JNK is then associated with an increase in of IHH ligand expression levels, which can be released by the hepatic stellate cells in the hepatic sinusoidal space. Circulating IHH ligand is intercepted by receptors exposed on the surface of hepatocytes and stimulates hepatocyte proliferation through the transcriptional activation of the IHH downstream transcription factor GLI1, which regulates the gene expression of the cell cycle regulator cyclin D1. Administration of SP600125 JNK inhibitor blocks activity of JNK with consequential reduction of IHH levels and hepatic regeneration. Surprisingly, administration of recombinant IHH ligand restores the nuclear levels of both JNK and active-JNK in SP600125-treated livers, suggesting that a positive feedback loop (dotted lines) exists for IHH in regulating levels of JNK in ALPPS regenerating livers. The mechanisms underlying the proposed model are, however, unclear. ALPPS, associating liver partition and portal vein ligation in staged hepatectomy. Journal of Hepatology 2018 69, 572-574DOI: (10.1016/j.jhep.2018.05.026) Copyright © 2018 European Association for the Study of the Liver Terms and Conditions